Cargando…

A pH-responsive T(1)-T(2) dual-modal MRI contrast agent for cancer imaging

Magnetic resonance imaging (MRI) is a non-invasive imaging technology to diagnose health conditions, showing the weakness of low sensitivity. Herein, we synthesize a contrast agent, SPIO@SiO(2)@MnO(2), which shows decreased T(1) and T(2) contrast intensity in normal physiological conditions. In the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hongwei, Chen, An, Zhang, Xindan, Wei, Zixiang, Cao, Rong, Zhu, Yi, Lu, Jingxiong, Wang, Zhongling, Tian, Leilei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792454/ https://www.ncbi.nlm.nih.gov/pubmed/36572677 http://dx.doi.org/10.1038/s41467-022-35655-x

Ejemplares similares

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Fe/Mn Multilayer Nanowires as High-Performance T(1)-T(2) Dual Modal MRI Contrast Agents
por: Cao, Xiaoming, et al.
Publicado: (2021)

L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent
por: Li, Jiali, et al.
Publicado: (2020)

Radiometal-Based PET/MRI Contrast Agents for Sensing Tumor Extracellular pH
por: Pollard, Alyssa C., et al.
Publicado: (2022)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Lymph node imaging using novel simultaneous PET/MRI and dual-modality imaging agent
por: Ko, Guen Bae, et al.
Publicado: (2015)

Rare-Earth Doped Particles as Dual-Modality Contrast Agent for Minimally-Invasive Luminescence and Dual-Wavelength Photoacoustic Imaging
por: Sheng, Yang, et al.
Publicado: (2014)

Tannic acid-mediated synthesis of flower-like mesoporous MnO(2) nanostructures as T(1)–T(2) dual-modal MRI contrast agents and dual-enzyme mimetic agents
por: Sorouri, Farzaneh, et al.
Publicado: (2023)

Low‐boiling Point Perfluorocarbon Nanodroplets as Dual‐Phase Dual‐Modality MR/US Contrast Agent
por: McHugh, Christian T., et al.
Publicado: (2022)

On-chip generation of microbubbles in photoacoustic contrast agents for dual modal ultrasound/photoacoustic in vivo animal imaging
por: Das, Dhiman, et al.
Publicado: (2018)

Organic nanoparticle-doped microdroplets as dual-modality contrast agents for ultrasound microvascular flow and photoacoustic imaging
por: Xu, Yu, et al.
Publicado: (2020)

Aluminium hydroxide stabilised MnFe(2)O(4) and Fe(3)O(4) nanoparticles as dual-modality contrasts agent for MRI and PET imaging
por: Cui, Xianjin, et al.
Publicado: (2014)

Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2021)

A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging
por: Liu, Yun, et al.
Publicado: (2018)

Microwave-Synthesized Platinum-Embedded Mesoporous Silica Nanoparticles as Dual-Modality Contrast Agents: Computed Tomography and Optical Imaging
por: Chu, Chia-Hui, et al.
Publicado: (2019)

A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging
por: Sun, Jinghua, et al.
Publicado: (2019)

Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI
por: Şologan, Maria, et al.
Publicado: (2019)

Dynamic, Simultaneous Concentration Mapping of Multiple MRI Contrast Agents with Dual Contrast - Magnetic Resonance Fingerprinting
por: Anderson, Christian E., et al.
Publicado: (2019)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

Monodisperse magnetic lecithin-PFP submicron bubbles as dual imaging contrast agents for ultrasound (US) and MRI
por: Waqar, Hira, et al.
Publicado: (2022)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
por: Chen, Zhijin, et al.
Publicado: (2009)

HematoPorphyrin Monomethyl Ether polymer contrast agent for ultrasound/photoacoustic dual-modality imaging-guided synergistic high intensity focused ultrasound (HIFU) therapy
por: Yan, Sijing, et al.
Publicado: (2016)

T (1)–T(2) dual-modal magnetic resonance contrast-enhanced imaging for rat liver fibrosis stage
por: Lu, Fulin, et al.
Publicado: (2022)

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics
por: Zhang, Yajie, et al.
Publicado: (2019)

Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes
por: Chen, Qingshan, et al.
Publicado: (2017)

Hyperpolarized (15)N-pyridine Derivatives as pH-Sensitive MRI Agents
por: Jiang, Weina, et al.
Publicado: (2015)

Cardiac pH-Imaging With Hyperpolarized MRI
por: Bøgh, Nikolaj, et al.
Publicado: (2020)

A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2008)

A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009)

Development of fluorescence/MR dual-modal manganese-nitrogen-doped carbon nanosheets as an efficient contrast agent for targeted ovarian carcinoma imaging
por: Han, Cuiping, et al.
Publicado: (2020)

Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents
por: Anderson, Christian E., et al.
Publicado: (2017)

MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
por: Zhou, Zhuxian, et al.
Publicado: (2015)

pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
por: Huang, Xi, et al.
Publicado: (2018)

Ratiometric pH-Responsive (19)F Magnetic Resonance Imaging Contrast Agents Based on Hydrazone Switches
por: Janasik, Dawid, et al.
Publicado: (2022)

Iron phosphide nanoparticles as a pH-responsive T(1) contrast agent for magnetic resonance tumor imaging
por: Qiu, Yuan, et al.
Publicado: (2019)

Smart nanomedicine agents for cancer, triggered by pH, glutathione, H(2)O(2), or H(2)S
por: Li, Yaping, et al.
Publicado: (2019)

Quantitative parameter mapping of contrast agent concentration and relaxivity and brain tumor extracellular pH
por: Matsumoto, Yuki, et al.
Publicado: (2022)

Development of (153)Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
por: Gholami, Amir, et al.
Publicado: (2016)

Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy
por: Yang, Huikang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7m97t438emi7gq0kg0k7e0v54e